Increased plasma MMP-9 levels generally predicted pulmonary status declines, including worsening transfer factor and lung density as well as greater COPD exacerbations in AATD-associated emphysema. This evidence concerns the gene MMP9 and alpha 1-antitrypsin deficiency.